[ad_1]
Climate change is a latent reality that would intensify by 2080. The outlook is daunting for infectious diseases that may be harmful to humans. However, manufacturers of pharmaceuticals They could benefit.
Because of high the temperatures Around the world, the health of nearly a billion people would be violated. People may be more likely to contract diseases such as Zika and Ebola.
YOU CAN SEE Africa: Two Million People May Be Infected by the Ebola Epidemic
The rapid spread of infectious diseases could cause climate change. According to badysts led by Matthew Harrison, health care specialist, Europe It would be the most hurt.
The demand for vaccines by 2080 would be important. according to Morgan Stanleythe $ 500 million infectious disease market could see an increase of $ 125 million.
The projection of treatments against infections caused by high temperatures would have a higher price because of their complexity.
YOU CAN SEE A mysterious virus spreading in Bolivia claimed the lives of three people
Organizations that manufacture vaccines are prepared for the proliferation of diseases infectious. Companies such as Sanofi, GlaxoSmithKline Plc and Merck & Co. already have resources configured for large-scale production.
It should be noted that the company Modern Inc. he has a vaccine against him Zika and a treatment for chikunguya development for 2080.
Source link